Inactive Instrument
Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Stocks
BLCM
US0794814048
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -6.68% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Maggio
CEO | Chief Executive Officer | 66 | 23/02/2024 |
Richard Fair
CEO | Chief Executive Officer | 58 | 31/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Fair
BRD | Director/Board Member | 58 | - |
Judith Kilmovsky
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.68% | -18.17% | - | - | 822K | |
| +3.00% | -0.69% | +71.86% | +127.18% | 55.78B | |
| +6.76% | +18.10% | +91.66% | +104.09% | 55.66B | |
| +3.33% | +4.51% | -11.68% | -11.91% | 23.84B | |
| +1.32% | +6.22% | +5.28% | +415.45% | 22.7B | |
| +6.82% | +6.79% | +38.75% | -29.28% | 16.12B | |
| -0.89% | +5.71% | +24.30% | +186.29% | 13.64B | |
| +9.96% | +15.98% | +157.65% | +310.89% | 14.8B | |
| +2.85% | +2.81% | +75.32% | +139.44% | 12.16B | |
| +6.17% | +10.22% | +163.15% | +166.44% | 11.85B | |
| Average | +3.24% | +7.40% | +68.48% | +156.51% | 25.17B | |
| Weighted average by Cap. | +4.39% | +7.70% | +66.61% | +142.90% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 6.2M 5.43M 5.01M 4.68M 8.81M 586M 9.01M 60.31M 23.28M 289M 23.28M 22.77M 1B | 1.5M 1.31M 1.21M 1.13M 2.13M 142M 2.18M 14.59M 5.63M 69.96M 5.63M 5.51M 243M |
| Net income | -9.7M -8.5M -7.84M -7.33M -13.79M -918M -14.1M -94.4M -36.44M -453M -36.45M -35.65M -1.57B | -24.97M -21.87M -20.19M -18.85M -35.48M -2.36B -36.29M -243M -93.78M -1.16B -93.78M -91.73M -4.04B |
| Net Debt | - | - |
Employees
13
